Cellares and Ori Biotech’s new cell therapy manufacturing contracts

PartnershipCAR-TNeutral

AI Analysis

Summary

Cellares has signed a partnership with Taiwanese company GenomeFrontier Therapeutics to evaluate manufacturing of the latter's CAR-T cell therapy, marking Cellares' first Asian partnership.

Outcome Details

Cellares to evaluate manufacturing of GenomeFrontier's CAR-T therapy

Importance:5/10

Sentiment:

0.20

cell therapymanufacturingpartnershipCAR-TAsia expansion

Related Companies

$ALPMY

Read the original article

Published by Endpoints News on September 17, 2026 4:47 PM

Read Original